These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 11363517)

  • 1. Ritonavir: first to prolong survival.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1996 Apr; 2(4):38-44. PubMed ID: 11363517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ritonavir, saquinavir combination--& warning.
    AIDS Treat News; 1995 Sep; (no 231):6. PubMed ID: 11362871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ritonavir/saquinavir trial announced.
    J Int Assoc Physicians AIDS Care; 1996 Apr; 2(4):59. PubMed ID: 11363522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roche submits NDA for Invirase.
    J Int Assoc Physicians AIDS Care; 1995 Sep; 1(8):37-8. PubMed ID: 11362796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on HIV protease inhibitors.
    Vella S
    AIDS Clin Care; 1995 Oct; 7(10):79-82, 88. PubMed ID: 11362832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New drugs for HIV infection.
    Med Lett Drugs Ther; 1996 Apr; 38(972):35-7. PubMed ID: 8606677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nipping HIV in the bud.
    Smart T
    GMHC Treat Issues; 1996 Aug; 10(8):3-6. PubMed ID: 11363719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matching up ritonavir with saquinavir.
    GMHC Treat Issues; 1996 Apr; 10(4):8. PubMed ID: 11363708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease inhibitors: ritonavir and saquinavir combination trial recruiting--seven U.S., Canada sites incl. San Francisco.
    AIDS Treat News; 1996 Apr; (no 245):1-3. PubMed ID: 11363621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [For the first time a combination of 2 protease inhibitors investigated].
    Schenk M
    Dtsch Med Wochenschr; 1996 Aug; 121(34-35):A36. PubMed ID: 8829900
    [No Abstract]   [Full Text] [Related]  

  • 11. Potent new AIDS drugs underscore promise of combination therapy.
    AIDS Alert; 1996 Jan; 11(1):1-4. PubMed ID: 11363225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conference looks at HIV drug resistance.
    Chang HE
    GMHC Treat Issues; 1995 Sep; 9(9):6-8. PubMed ID: 11362910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease inhibitors.
    Treat Rev; 1996 Aug; (No 22):2-7. PubMed ID: 11363815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDA approves 2 new protease inhibitors: ritonavir (Norvir) and Crixivan (Indinavir sulfate). Food and Drug Administration.
    Schouten JT
    STEP Perspect; 1996; 8(1):7-8. PubMed ID: 11363592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ritonavir, Abbott protease inhibitor, approved.
    AIDS Treat News; 1996 Mar; (no 243):2-3. PubMed ID: 11363300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease inhibitors and prevention of cross resistance.
    Levin J
    AIDS Treat News; 1995 Oct; (no 232):1-3. PubMed ID: 11362875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protease inhibitors shine in triple combinations.
    AIDS Alert; 1996 Mar; 11(3):31-2. PubMed ID: 11363243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saquinavir: combination shows survival benefit; new formulation trial recruiting.
    AIDS Treat News; 1996 May; (no 246):1-2. PubMed ID: 11363484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No tease this time--pros and cons of a long-awaited anti-HIV drug.
    Chang HE
    Posit Aware; 1996; 7(1):18-20. PubMed ID: 11363118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abbott agrees to expanded access for ritonavir.
    Baker R
    BETA; 1995 Sep; ():4. PubMed ID: 11362891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.